The Saljar Group - working with innovators

Innovation is a risky business! Click here to see why + how we can help

Share our site...

Please click each button for more information

Members of our team and network have a range of skills that are relevant to innovative and high-technology organisations. These skills include legal, finance, accounting, marketing and scientific/engineering skills.

Skills

•	establishing and advising start-up companies based on innovation and/or high-technology assets
•	helping high-technology start-up companies with the capital-raising process
•	negotiating a wide range of international deals and agreements involving innovative/high-technology projects and entities
•	providing commercial and legal advice and services relevant to a range of commercial and operational activities undertaken by innovative and high-technology organisations
•	litigation to protect intellectual property rights
•	valuation of intellectual property rights
•	managing high-technology commercial development projects
•	developing patenting and IP protection strategies
•	developing commercialisation and marketing plans for the commercial deployment of high-technology assets
•	negotiating international IP/technology assignment and licensing deals

Experience

Members of our team have been involved in the establishment, conduct and/or management of a wide variety of projects and deals involving a wide variety of innovative and high technology organisations. Examples include the matters and organisations listed below.

Matters

Organisations

Clients & Experience

We work with innovators. Click each image below for information about how we've helped innovators in the past.

How we've helped

•	Cooperative Research Centre for Biomedical Imaging Development: a multi-participant research organisation. Participants include [list them, with links];
•	Garvan Institute of Medical Research: a leading and internationally renowned research organisation.
•	Global Medical Solutions - a producer and supplier of high-technology healthcare products and services. <http://www.gms-aus.com/home.html>
•	Key Options Technology: an IT solutions and specialised services technology development company;
•	Microflow Pty Ltd: a high-technology engineering start-up company;
•	ST Vincent's hospital: one of the leading research/teaching hospitals in the Asia-Pacific region.
•	SydPath Pathology: a high-technology service provider and technology development organisation (<http://www.sydpath.com.au/>)

Alphapharm
ANSTO Inc
Applimex
Arafura Resources NL
Australian Customs Service
Australian Membrane Technologies
Australian Nuclear Science and technology Organisation (ANSTO)
Australian Scientific Instruments
Australian Synchrotron Corporation
Bayer Schering PS
BC Cancer
BHP Billiton
BHP Billiton Olympic Dam Corporation
BHPB Billiton Innovation
Bluglass
British Nuclear Fuels Group
Burkert
Cadbury-Schweppes
Canberra Hospital
Cardinal Health
Ceramisphere
Ciba
Comalco
Connell Wagner
CRC for Asthma
CRC for Biomedical Imaging Development
CRC for Polymers
CRC for Welded Structures
CSIRO
Cth Attorney General's Department
Cth Defence Science and Technology Organisation
Cth Department of Defence
Cth Department of PM and Cabinet
Cth Department of Transport and Regional Security
CVRD Brazil
Cyclopharm
Defence Materials Technology Centre
EADS France
Gambro AG
Garvan Institute of Medical Research
GE Healthcare India
GlaxoSmithKlineGlobal Medical Solutions
The Jackson Laboratory
Johnson & Johnson Research
Key Options Technology
Lantheus
MAP Biomedical (Finland)
MDS Nordion (Canada)
Microflow
Mosaic Mining
NDA (UK)
NSW Department of Environment and Conservation
NSW Department of Health
NTP South Africa
Opal Therapeutics
Origin Energy
Peptech
Peter McCallum Cancer Institute
Procter & Gamble
Rio Tinto
Rocla
Saint Gobain
Schizophrenia Research Institute
Siemens Medical Solutions
South African Nuclear Energy Corp
St Jude Children's Research Hospital
St Vincent's Hospital
Sydney Water Corporation
Telstra
Tyco
University - Australian National
University - Cambridge
University - Deakin
University - Harvard
University - Louisville
University - Taiwan National Central
University - Yale
University of Newcastle
University of NSW
University of Otago
University of QLD
University of Sydney
University of Western Australia
University of Western Sydney
University of Wollongong
Uranium Equities Ltd
Urtek Mining
Walter & Eliza Hall Institute of Medical Research
Worley Parsons

Commercial & Legal

Providing commercial and legal advice and services relevant to a range of commercial and operational activities undertaken by innovative and high-technology organisations

Litigation to protect intellectual property rights

Negotiating international IP/technology assignment and licensing deals

Valuation and Commercialisation

Valuing intellectual property rights and high-technology assets

Managing high-technology commercial development projects

Developing patenting and IP protection strategies

Developing commercialisation and marketing plans for the commercial deployment of the outcomes of innovation

Negotiating international IP/technology assignment and licensing deals

Establishing and advising innovative and/or high-technology start-up companies

Helping high-technology start-up companies with the capital-raising process

Litigation to protect intellectual property rights

Licensing

Developing commercialisation and marketing plans for the commercial deployment of high-technology assets

Negotiating international IP/technology assignment and licensing deals

Start-Ups

Establishing and advising innovative and/or high-tech start-up companies

Helping high-tech start-up companies with the capital-raising process

Negotiating a wide range of international deals and agreements involving innovative/high-technology projects and entities

Providing commercial and legal advice and services to innovative and high-technology organisations

Litigation to protect intellectual property rights

Valuation of intellectual property rights

Managing high-technology commercial development projects

Developing patenting and IP protection strategies

Developing commercialisation and marketing plans for the commercial deployment of high-technology assets

Negotiating international IP/technology assignment and licensing deals

Innovation/IP Management

Conducting audits and training regarding proper conduct and management of innovation

Valuation of intellectual property rights

Managing high-technology commercial development projects

Developing patenting and IP protection strategies

Developing commercialisation and marketing plans for the commercial deployment of high-technology assets

Negotiating international IP/technology assignment and licensing deals

Protecting IP

Litigation to protect intellectual property rights

Conducting audits and training regarding proper conduct and management of innovation

Developing patenting and IP protection strategies

Providing commercial and legal advice and services to innovative and high-technology organisations

Managing high-technology commercial development projects

Developing commercialisation and marketing plans for the commercial deployment of high-technology assets

Negotiating international IP/technology assignment and licensing deals

Alphapharm
ANSTO Inc
Applimex
Arafura Resources NL
Australian Customs Service
Australian Membrane Technologies
Australian Nuclear Science and Technology Organisation (ANSTO)
Australian Scientific Instruments
Australian Synchrotron Corporation
Bayer Schering PS
BC Cancer
BHP Billiton Ltd
BHP Billiton Olympic Dam Corporation
BHPB Billiton Innovation
Bluglass
British Nuclear Fuels Group
Burkert
Cadbury-Schweppes
Canberra Hospital
Cardinal Health
Ceramisphere
Ciba
Comalco

Connell Wagner
CRC for Asthma
CRC for Biomedical Imaging Development
CRC for Polymers
CRC for Welded Structures
CSIRO
Cth Attorney General's Department
Cth Defence Science and Technology Organisation
Cth Department of Defence
Cth Department of PM and Cabinet
Cth Department of Transport and Regional Security
CVRD Brazil
Cyclopharm
Defence Materials Technology Centre
EADS France
Gambro AG
Garvan Institute of Medical Research
GE Healthcare India
GlaxoSmithKline
Global Medical Solutions
The Jackson Laboratory

Johnson & Johnson Research
Key Options Technology
Lantheus
MAP Biomedical (Finland)
MDS Nordion (Canada)
Microflow
Mosaic Mining
NDA (UK)
NSW Department of Environment and Conservation
NSW Dept of Health
NTP South Africa
Opal Therapeutics
Origin Energy
Peptech
Peter McCallum Cancer Institute
Procter & Gamble
Rio Tinto
Rocla
Saint Gobain
Schizophrenia Research Institute
Siemens Medical Solutions
South African Nuclear Energy Corp

St Jude Children's Research Hospital
St Vincent's Hospital
Sydney Water Corporation
Telstra
Tyco
University - Australian National
University - Cambridge
University - Deakin
University - Harvard
University - Louisville
University - Taiwan National Central
University - Yale
University of Newcastle
University of NSW
University of Otago
University of QLD
University of Sydney
University of Western Australia
University of Western Sydney
University of Wollongong
Uranium Equities
Urtek Mining Ltd
Walter & Eliza Hall Inst of Med Research
Worley Parsons

www.microflow.com.au

Microflow Pty Ltd is a high-technology engineering start-up company that has developed platform technology with energy-saving and water-saving applications. Our contribution to Microflow = Advice and assistance re capital raising, commercialisaton strategy development and implementation, as well as negotiation of major collaboration and international licensing deals with a number of multinational organisations.

www.stvincents.com.au

St Vincent's Hospital, through its various research units (including its Centre for Applied Medical Research, Research & Biotechnology Precinct, Clinical Trials Centre and Centre for Immunology) is one of the leading research/teaching hospitals in the Asia-Pacific region. Our contribution to St Vincent's = Commercial legal and IP commercialisation services - including re collaboration and licensing, and assistance with financial modelling, business planning and the development of commercialisation and marketing strategies for innovative treatment programs.

www.sydpath.com.au

SydPath Pathology is a high-technology service provider and technology development organisation. Our contribution to SydPath = Assistance with strategy and business management projects.

www.crcbid.com.au

The Cooperative Research Centre for Biomedical Imaging Development is a multi-participant research organisation. Participants include ANSTO, Berthold, Cyclotek, The Garvan Institute of Medical Research, GE Healthcare, Monash University and Peter MacCallum Cancer Centre. Our contribution to CRCBID = Ongoing IP management and commercialisation services, including re the valuation of IP and the development of commercialisation strategies across a broad range of diverse research programs covering life sciences and computer science/physics/engineering.

www.garvan.org.au

The Garvan Institute of Medical Research is a world leader in biomedical research, pioneering study into some of the most widespread diseases affecting our community today. Our contribution to Garvan = Commercial legal services to Garvan's Business Development Unit in connection with Garvan's commercial interactions with third parties, collaboration with research partners and the licensing/commercialisation of research outcomes.

www.gms-aus.com

Global Medical Solutions is a leading provider of prepared, time-critical radio-pharmaceuticals and other products relating to radiation protection and detection, as well as comprehensive value-added pharmacy and quality control services, in fields such as Nuclear Medicine, Positron Emission Tomography Centres, Diagnostic Imaging and Radiation Oncology/Brachytherapy. Our contribution to GMS = Commercial legal advice and contract negotiation - including re key contracts and the formation of international alliances.

www.keyoptions.com.au

Key Options Technology is an IT solutions and specialised IT services and technology development company. Our contribution
to Key Options = Commercial legal advice and contract negotiation - including re key customer contract negotiation.

Some examples (click links below for press releases)

International high-tech collaboration and cross-licensing
Complex projects: International technology development project with cross licensing arrangements between industry organisations.
(Contributions related to development of financial models/deal structure and negotiation of commercial and legal terms of those components of the broader deal that related to ANSTO)

Innovator-to-industry licensing (click links)
High-tech: Technology development and licence agreement.
Medical: Licence to global pharmaceutical company (Bayer SP).
(Contributions related to development of financial models/deal structure and negotiation of commercial and legal terms)

Collaboration agreements (click links)
International: Medical research collaborations with Cambridge and Harvard Unis.
Major: Medical research collaboration with CSIRO.
(Contributions related to structure and negotiation of commercial and legal terms)

Start-up assistance & incubation (click links)
CeramiSphere: Contributions related to structuring and negotiating licensing arrangements and project agreements with global partners such as EADS during incubation.
Microflow: Contributions related to the development of financial models/deal structure and negotiation of commercial and legal terms with multinational technology leaders (details confidential) and assistance with commercialisation strategy development and the capital raising process.

Tender preparation - high-technology equipment and services for hospitals
November 2011
We provided advice and assistance to a supplier of high-technology goods and services, in relation to the submission of a tender to supply goods and services to expand the high-tech facilities at a large hospital.

IP management issues - biotech start-up
November 2011
We provided advice and assistance to a biotech start-up regarding IP management and IP risk in relation to the development and commercialisation of a novel treatment for a medical condition.

IP development and royalty agreement - high-technology industrial equipment
November 2011
We advised on an arrangement regarding the development and payment of royalties in relation to high-technology industrial equipment.

MoU regarding medical health initiative across countries
November 2011
We provided advice and assistance to a research organisation in relation to the establishment of an MoU with an overseas research organisation aimed at improving eye-care skills, facilities and technology.

Start-up issues re capital raising, business-model and commercialisation - cleantech
November 2011
We provided assistance to a cleantech start-up regarding company structure, capital raising and investment, IP management, business-model development and commercialisation.

Exclusive distribution arrangements - European company - medical technology
November 2011
We advised on an exclusive distribution arrangement regarding distribution of medical technology products developed by a Europe-based company.

Spin-out, cross-investment capital raising, and licence - medical diagnosis technology
October 2011
We advised and assisted a research organisation in relation to the establishment of a spin-out, cross-investment (with preferential rights) capital-raising with a US-based entity, and the licensing of medical diagnosis technology.

Web-based social media start-up - establishment and commercialisation
September 2011
We provided advice and assistance to a social media start-up about corporate structure, capital raising, IP management, business-model development and commercialisation.

Product development/commercialisation - domestic and industrial construction
August 2011
We provided advice regarding the IP management and commercialisation issues and risks faced in relation to the development and commercialisation of a high-technology product for use in domestic and industrial markets.

IP ownership issues - jointly-employed researchers
August 2011
We provided advice and assistance to a research organisation about IP-ownership issues regarding jointly-employed researchers.

IP licence, manufacturing rights and IP transfer arrangement - high-tech products
August 2011
We provided advice and assistance to a developer of high-technology products regarding an arrangement under which IP rights were licensed, ongoing manufacturing and development arrangements were addressed, and IP transferred.

International collaboration, licence and royalty issues
July 2011
We provided advice and assistance to a large research organisation regarding its collaboration with an international collaborator, including in relation to licensing and commercialisation of new technology and the payment of royalties.

Regulatory issues - high technology products
July 2011
We assisted a high-technology company in relation to issues regarding the regulatory environment that applied to its high-tech goods and services.

Doing business - debtors based overseas
July 2011
We provided advice and assistance to a high-technology company regarding management of overseas-based debtors to whom high-technology goods and services had been provided.

Company governance - directors' duties and indemnities
July 2011
We provided advice and assistance to a high-technology company regarding directors' duties and indemnification of company directors.

IP escrow and licensing - high technology goods
July 2011
We put together an IP licence and US-based escrow agreement to assist a supplier of high-technology products manage its export relationship with a key overseas customer.

Doing business - commercial legal advice to high technology goods and services provider
June 2011
We provided commercial legal advice to a high-technology goods and services provider in relation to its commercial agreements and interactions with key suppliers and customers.

Commercialisation strategy - patented technology - leisure, tourism and industry
June 2011
We provided advice about the protection, valuation and commercialisation (including licensing) of patented technology with leisure, tourism and general industrial applications.

Development and expert consultant agreements - international parties - research organisation
May 2011
We provided advice about development and expert consultant agreements entered into by a research organisation and parties based in Europe and the USA.

Executive options plan advice and implementation - life sciences spin-out
May 2011
We provided advice about, and assisted with the implementation of, executive options and incentive plans for senior executives recruited to a spin out company formed by a life sciences research organisation.

Strategic IP management and commercialisation advice - entertainment site and e-commerce site
April 2011
We provided advice about IP management issues, as well as strategic commercialisation and capital raising advice, to help enhance the commercial returns from two separate websites: an innovative entertainment website and an innovative e-commerce B2C and B2B website.

Strategic IP management and commercialisation advice - technology and mobile commerce
April 2011
We provided advice about IP management issues, as well as strategic commercialisation and capital raising advice, to help enhance the commercial returns from innovative clean-technology that had the potential to be combined with mobile commerce applications.

Commercial supply of high-technology goods and services - international customer
March 2011
We helped a client finalise an agreement for the supply of high technology good and services to a major international customer.

Prior art search; strategic IP and product development advice - personal care
March 2011
We conducted a prior art search and provided advice about IP strategy and issues, patenting considerations, product development strategy and the engagement of collaborators in relation to a personal care product development project.

Capital raising advice - technology start-up - tourism and leisure
March 2011
We provided advice about issues and considerations with respect to the raising of angel and venture capital by a high-technology start-up business operating in the tourism and leisure market.

Licensing and royalty negotiations - multinational licensee - engineering
March 2011
We advised on royalty determination and other key issues in relation to an exclusive product development and licence agreement being negotiated with a Europe-based multinational in connection with innovative engineering technology developed by our client.

Product development project - personal care
February 2011
We provided preliminary advice about IP development, protection, valuation and commercialisation regarding an innovative personal care product development project.

IP protection and commercialisation advice
February 2011
We provided a technology developer with preliminary advice about the protection and commercialisation of novel physical products for the consumer outdoor sports market.

Negotiation with service providers - technology project
January 2011
We assisted with the process of negotiating with various technology service providers in relation the establishment of a project to develop and commercialise an innovative product/service offering aimed at promoting health and well-being.

IP protection and commercialisation advice - innovative services model
January 2011
We provided preliminary advice in relation to the protection and commercialisation of an innovative service-provision model aimed at corporate customers.

Establishment of innovation based venture
January 2011
We assisted with preliminary business planning and market research activities as part of the establishment of a new innovation-based products/services venture.

Contracts with key customers - export of high-technology products and services
December 2010
We helped a client with negotiations with a US-based customer regarding the export of high-technology products and services.

IP due diligence and IP ownership issues
December 2010
We helped a client identify and address issues with respect to ownership of IP developed by research team members and collaborators.

Licensing of technology for local supply and export of product
December 2010
We provided advice regarding an exclusive licence (based on patent rights and know-how rights) to facilitate both local and overseas manufacture and supply of products made using technology developed by our client.

Contracts with key customers - export of high-technology products and services
November 2010
We helped a client negotiate major contracts with key international customers regarding the export of high-technology products and services.

Pre-patenting process efficiencies - physics/computer science/IT/electrical engineering
November 2010
We helped our client collate information from researchers across a number of institutions and undertake a pre-patenting analysis to help determine whether seeking patent protection is appropriate and, if so, to identify the issues and information necessary to allow the subsequent interactions with patent attorneys to proceed without undue wasted time and expense.   This related to various technologies in the physics/computer science/IT/electrical engineering space.

Grant funding application for commercialisation
November 2010
We helped a client file an application for a Commonwealth government grant to assist with the commercialisation of the client's technology.

National phase entry recommendation re patent rights
October 2010
We provided advice to a client to assist with the process of determining which jurisdictions to enter national phase with respect to the application for patent rights in relation to cancer technology.

Capital raising - technology start-up
October 2010
We helped a high-technology start-up address issues regarding the capital raising process and the preparation of investor information.

Establishment of innovative online services business
October 2010
We helped a client address key legal issues, and drafted relevant agreements/terms, regarding the establishment of an innovative online services business.

Commercial opportunity and IP due-diligence information for investors and licensees
October 2010
We developed a document for prospective licensees and investors, outlining the nature and scope of the commercial opportunity as well as information relevant to an investor/licensee IP due-diligence, in relation to technology that has potential global application to human healthcare.

Successful government grant application
October 2010
We successfully applied for a merit-based government grant. The grant related to the development of innovative technology as part of the establishment and development of a new venture.

IP valuation and financial model - technology-based treatment
October 2010
We finalised a model to help determine uptake and operating costs regarding an innovative technology-based service developed by our client.

IP protection and commercialisation advice - IT-based consumer services venture
October 2010
We provided preliminary advice in relation to the protection and commercialisation of an innovative IT based-consumer services venture.

Pre-patenting process efficiencies - chemistry and life sciences
October 2010
We helped our client collate information from researchers across a number of institutions and undertake a pre-patenting analysis to help determine whether seeking patent protection is appropriate and, if so, to identify the issues and information necessary to allow the subsequent interactions with patent attorneys to proceed without undue wasted time and expense.   This related to various technologies in the chemistry and life sciences space.

Strategic issues and opportunities
October 2010
We helped a technology-based business address strategic issues relevant to its business.

Advising on IP-ownership, patenting and licensing/commercialisation
September 2010
We provided advice in relation to IP ownership, patentability and licensing/commercialisation of technology developed by researchers who had a complicated IP-ownership situation because of the circumstances of interactions with various external parties.

Alliance for commercialisation of innovative treatment tools
September 2010
We advised on the creation of an alliance between large organisations regarding the commercial deployment of innovative human health treatment tools.

Recommendation re commercialisation strategy
August 2010
We prepared a recommendation for the Board of a research organisation regarding commercialisation options and strategy with respect to an innovative production technology.

Cost model and IP valuation - process of production of cancer diagnosis tools
August 2010
We developed a model to identify inefficiencies in the cost structure of a production process in order to help value an efficiency-improving production technology.

Global patent licensing - commercialisation of innovative cancer diagnosis technology
July 2010
We finished helping a research organisation with the process of granting a worldwide licence as part of its commercialisation of innovative cancer diagnosis technology.

High-technology supply agreement finalised
July 2010
We helped a research organisation finalise an agreement with a global supplier for the supply of high-technology research tools that will enhance the quality of research into a range of medical conditions.

Helping with commercialisation of ground-breaking imaging technology aimed at improving patient outcomes
June 2010
We attended an internal two-day conference held by a client at which cutting-edge research into the development and use of medical imaging tracers and ground-breaking medical imaging technology, as well as the management and commercialisation of IP in relation to such research, was discussed. This research could significantly help improve patient treatment for patients with cancer, cardio-vascular diseases, brain tumours, epilepsy, Alzheimer's disease and other conditions.

Engagement with key clients
June 2010
We finished helping a communications technology services provider engage in commercial negotiations with a major strategic client.

Exciting medical research re immuno-therapy
June 2010
We finished helping two prestigious medical research organisations put together a medical research collaboration that could facilitate development of immuno-therapy for coeliac disease, autoimmune and allergic diseases.

Commercialisation analysis re innovative tumour diagnosis
June 2010
We presented a preliminary commercialisation analysis to a client regarding technology that has applications in relation to tumour diagnosis.

Resource model and IP valuation - innovative medical treatment service
May 2010
We developed a resource-requirements model to help forecast the type and cost of resources that would be required for the sustainable commercial implementation of an innovative technology-based service developed by our client.

Performance management for high-technology research and service organisation
May 2010
We assisted a high-technology services and research organisation with the management of commercial performance issues affecting its business operations.

Commercialisation strategy for innovative mental health treatment programs
April 2010
We presented a preliminary commercialisation strategy to a client for the commercially sustainable deployment of innovative mental health treatment programs.

Establishment of innovative online business
April 2010
We finished helping an innovative new on-line business finalise its business model, as well as helping with commercial and legal aspects of its online presence and operations and with IP protection.

Collaboration and commercialisation - exciting medical research re asbestos diseases
March 2010
We finished helping three medical research organisations put together a medical research collaboration and commercialisation arrangement aimed at helping improve understanding of asbestos-related diseases.

Spin-out of high-tech services company
March 2010
We provided preliminary advice and assistance to a client about the establishment of a start-up company to provide high-technology services.

Collaboration and commercialisation - exciting medical research re diabetes
March 2010
We finished helping two major medical research universities finalise a collaboration and commercialisation arrangement with a global biotech and a global pharmaceutical company aimed at developing tools to increase understanding of diabetes.

Exciting medical research re gene research and HIV
February 2010
We finished helping research collaborators come to an arrangement regarding the sharing of high technology processes and materials to be used in research regarding gene-silencing, stem cells and HIV research.

Global patent licensing - commercialisation of cutting edge engineering technology
January 2010
We finished helping a high-technology start up finalise an international patent licence with an Asian based licensee as part of its commercialisation of cutting edge engineering technology.

Exciting medical research re blood cells
December 2009
We finished helping major medical research organisations with a collaboration and commercialisation arrangement regarding research into lymphocytes and plasma cells.

Global patent licensing - commercialisation of cutting edge engineering technology
October 2009
We finished helping a high-technology start up finalise an international patent licence as part of its commercialisation of ground-breaking engineering technology.

Do you have a passion for innovation and commercialisation? We are recruiting!
We are looking for outstanding contributors to join our team. We offer exciting work with leading innovators. We offer outstanding reward structures and flexibility. Please visit our "People & Talent" page for further details.

Recent matters and news

www.amr.org.au

The St Vincent's Centre for Applied Medical Research conducts research in the fields of cancer, immunology, cell biology, allergy, inflammatory disease, HIV/AIDS, stem cells, neurobiology, cytokines and structural biology. Our contribution to the AMR = Commercial legal services in relation to commercial interactions with third parties, collaboration with research partners and the licensing/commercialisation of research outcomes.

www.radpharm.com.au

Radpharm Scientific is one of Australia's leading GMP-certified pharmaceutical manufacturers. It manufactures lyophilized and liquid pharmaceuticals, sterile pharmaceutical vials and components, and products for use in both human and veterinary clinical trials. It also provides GMP consulting, validation, QC, project management and regulatory registration and compliance services. Our contribution to Radpharm = Commercial legal advice and contract negotiation - including re key contracts with major international customers and allies.

www.brienholdenvision.org

The Brien Holden Vision Institute is dedicated to the advancement of eye care research, education and industry. It undertakes and funds a range of research projects directed towards improved understanding of the eye and the development of new vision correction products and systems. Our contribution to BHVI = Commercial legal services in connection with BHVI's collaboration with research partners, as well as the management and commercialisation of research outcomes.

www.visioncrc.org

The Vision Cooperative Research Centre (Vision CRC) is a collaboration of researchers and industry partners from around the world, drawn together to deliver innovative solutions to common eye conditions such as myopia, presbyopia and hyperopia - problems that affect the vision of billions worldwide. Our contribution to Vision CRC = Commercial legal services in connection with Vision CRC's collaboration with research partners, as well as the management and commercialisation of research outcomes.

www.intellidesign.com.au

Intellidesign is a multidisciplinary electronic design company offering a complete turnkey service, from concept to manufacture. It develops electronic devices for use in a wide range of applications and environments, from hospitals to underground mines. Our contribution to Intellidesign = Commercial/legal services in connection with Intellidesign's dealings with local and international customers, as well as the management and commercialisation of IP.